Results for tag: "Cutaneous Lupus Erythematosus"

Cutaneous Lupus Erythematosus (CLE) is a type of autoimmune disorder that affects the skin. It is characterized by a rash that can appear on the face, neck, and other areas of the body. The rash is often red and scaly, and can be accompanied by itching and burning. CLE is caused by an overactive immune system, which leads to inflammation and damage to the skin. Treatment for CLE typically involves medications that suppress the immune system, such as corticosteroids and immunosuppressants. In some cases, phototherapy may also be used to reduce inflammation. The market for Immune Disorders Drugs related to CLE is highly competitive, with a range of products available from various manufacturers. These products include topical creams, oral medications, and injectable drugs. Many of these products are designed to reduce inflammation and suppress the immune system, while others are designed to treat the symptoms of CLE. Companies in the Cutaneous Lupus Erythematosus market include AbbVie, Pfizer, Novartis, and GlaxoSmithKline. These companies offer a range of products designed to treat CLE, including topical creams, oral medications, and injectable drugs. Show Less Read more